22 May 2013
Keywords: highlights, smithkline, portfolio, george, poste, chairman, research
Article | 02 January 1995
George Poste, chairman of research and development at SmithKline
Beecham, believes the company has a fertile mid-stage pipeline which
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 January 1995
16 January 1995
21 May 2013
© 2013 thepharmaletter.com